Taletrectinib adipate is under clinical development by Nuvation Bio and currently in Phase I ... The drug candidate targets tyrosine kinases ROS1 and NTRKs type 1, 2, 3. The drug candidate was under ...

Itacitinib adipate is under clinical development by Incyte and currently in Phase III for Graft Versus Host Disease (GVHD). According to GlobalData, Phase III drugs for Graft Versus Host Disease (GVHD ...

The Bureau of Indian Standards (BIS) has released a draft document that outlines principles for self-governance in the ecommerce sector. The initiative is designed to promote ethical practices ...

Nintendo revealed the Switch 2 via a several-minute-long YouTube trailer that showed off the new console's contours and a single Mario Kart game but little else. The Switch 2 was rumored for a ...

Nintendo has finally revealed the Switch 2 with a video that confirms a number of new features while sparking burning questions for fans to discuss. While pre-announce leaks proved to be pretty ...

He joined The Verge in 2019 after nearly two years at Techmeme. Nintendo shared the first details about the Nintendo Switch 2 in a video published Thursday. Nintendo doesn’t give a specific ...

Nintendo has unveiled the long-awaited successor to its popular Switch video game console: the Nintendo Switch 2. First-look images at the console design and a teaser trailer were revealed by ...

Just days before Trump takes office, the BIS-published report said the world economy was on track for a "soft landing" but it stressed growing uncertainty due to what it described as the new ...

The Nintendo Switch 2 has been confirmed, and we'll find out more about it in a Nintendo Direct focused on the new console that's coming in early April. In a video released a few minutes ago ...

The Bank for International Settlements faces mounting pressure to revamp its internal think tank devoted to driving technological change in central banking, according to people familiar with the ...

The strategy’s framework also defines certain exemptions on licenses and authorizations to ensure that risk-free commercial chip deals proceed and AI benefits are widely shared, BIS said Monday.